Wellcome Launches 10-Year QuestWellcome Launches 10-Year Quest
February 26, 2010
LONDON The Wellcome Trust, a London-based global charity organization supporting biomedical research, unveiled an ambitious ten-year plan challenging researchers to find bold solutions to the most important questions facing our understanding of health and disease. Wellcome Trust funds will provide outstanding researchers with the time, resources and infrastructure necessary to make significant advances, concentrating efforts to address five key challenges in human and animal health. These include:
Maximizing the health benefits of genetics and genomics: Understanding how genes affect our health and disease to develop new ways to diagnose, treat and prevent illness.
Understanding the brain: Exploring how the billions of nerves in the brain allow us to think, learn and remember, so that we can find new approaches to treating mental illness and neurological disorders such as stroke, Parkinsons and Alzheimers diseases.
Combating infectious disease: Examining the link between infectious disease in animals and humans to develop new ways to prevent, diagnose and treat the bacterial, viral and parasitic diseases that kill millions of people worldwide every year.
Investigating development, aging and chronic disease: Understanding how the human body develops, functions and ages, so that we can tackle the growing burden of chronic disease across the world.
Connecting environment, nutrition and health: Developing new initiatives to examine critical issues such as malnutrition and obesity, and the health impacts of climate change and population migration.
Sir Mark Walport, director of the Wellcome Trust, said, We face many serious challenges, including aging populations, the threat of global climate change and the emergence of new diseases. The Wellcome Trust is extraordinarily well positioned to give researchers the freedom and security to pursue the questions that will provide answers to these challenges. But scientific discoveriesand their application to patient benefittake time, and that is why we are setting out our plans for the next decade.
You May Also Like
CRN petition to FTC: RCTs aren’t required to substantiate ‘health-benefit’ claimsSep 22, 2023
Collagen peptide ingredient solutions for seniors’ changing needs – infographicSep 19, 2023
Radicle Insights—Covid Eris and dietary supplements: separating fact from fictionSep 21, 2023
More bioavailable hyaluronic acid complex for today’s beauty-from-within consumer – snapshotSep 18, 2023